The definitive global resource for rare diseases and orphan drugs, offering a comprehensive nomenclature, an encyclopedia of conditions, and a directory of specialized care centers and diagnostic laboratories across 40 countries.

A centralized registry and results database of publicly and privately funded clinical studies conducted around the world, managed by the U.S. National Library of Medicine to provide transparency in medical research.

The Genetic and Rare Diseases Information Center (GARD) provides the public with free, easy-to-understand information on rare and genetic conditions, translating complex scientific data into actionable resources for patients and families.

The National Organization for Rare Disorders (NORD) is a primary advocacy organization providing patient assistance programs, education, and research grants while lobbying for legislation that benefits the 30 million Americans with rare diseases.

A leading international non-profit that builds and unites the rare disease community by equipping patient advocates with tools, training, and resources to accelerate research and widen the drug development pipeline.

The Rare Diseases Clinical Research Network (RDCRN) facilitates collaborative research through a network of 20+ consortia, focusing on natural history studies, clinical trial readiness, and the training of new investigators in the field.

The definitive global resource for rare diseases and orphan drugs, offering a comprehensive nomenclature, an encyclopedia of conditions, and a directory of specialized care centers and diagnostic laboratories across 40 countries.

A centralized registry and results database of publicly and privately funded clinical studies conducted around the world, managed by the U.S. National Library of Medicine to provide transparency in medical research.

The Genetic and Rare Diseases Information Center (GARD) provides the public with free, easy-to-understand information on rare and genetic conditions, translating complex scientific data into actionable resources for patients and families.

The National Organization for Rare Disorders (NORD) is a primary advocacy organization providing patient assistance programs, education, and research grants while lobbying for legislation that benefits the 30 million Americans with rare diseases.

A leading international non-profit that builds and unites the rare disease community by equipping patient advocates with tools, training, and resources to accelerate research and widen the drug development pipeline.

The Rare Diseases Clinical Research Network (RDCRN) facilitates collaborative research through a network of 20+ consortia, focusing on natural history studies, clinical trial readiness, and the training of new investigators in the field.